Back to Search Start Over

Easy and robust electrotransfection protocol for efficient ectopic gene expression and genome editing in human B cells

Authors :
Franck M. Andre
Yegor S. Vassetzky
Anna A. Shmakova
Diego Germini
Reynand Jay Canoy
Joëlle Wiels
Marc Lipinski
Aspects métaboliques et systémiques de l'oncogénèse pour de nouvelles approches thérapeutiques (METSY)
Institut Gustave Roussy (IGR)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)
University of the Philippines (UP System)
Vectorologie et thérapeutiques anti-cancéreuses [Villejuif] (UMR 8203)
Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Centre National de la Recherche Scientifique (CNRS)
Institut Gustave Roussy (IGR)
Signalisation, noyaux et innovations en cancérologie (UMR8126)
Koltzov Institute of Developmental Biology
the Russian Academy of Sciences [Moscow, Russia] (RAS)
Source :
Gene Therapy, Gene Therapy, Nature Publishing Group, In press, ⟨10.1038/s41434-020-00194-x⟩
Publication Year :
2020
Publisher :
Springer Science and Business Media LLC, 2020.

Abstract

International audience; B-cell lines and primary PBMCs are notoriously hard to transfect, thus making genome editing, ectopic gene expression, or gene silencing experiments particularly tedious. Here we propose a novel efficient and reproducible protocol for electrotransfection of lymphoblastoid, B-cell lymphoma, leukemia cell lines, and B cells from PBMCs. The proposed protocol requires neither costly equipment nor expensive reagents; it can be used with small or large plasmids. Transfection and viability rates of about 79% and 58%, respectively, have been routinely achieved by optimizing the salt concentration in the electrotransfection medium and the amount of plasmid used. A validation of the protocol was obtained via the generation of a TP53 −/− RPMI8866 lymphoblastoid cell line which should prove useful in future hematological and blood cancer studies.

Details

ISSN :
14765462 and 09697128
Volume :
30
Database :
OpenAIRE
Journal :
Gene Therapy
Accession number :
edsair.doi.dedup.....8e416a6d6563665c0187b20fe7e991a6